{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T17:48:36Z","timestamp":1791913716374,"version":"4.3.4"},"reference-count":177,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:00:00Z","timestamp":1648080000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.ijcard.2022.03.050","type":"journal-article","created":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T20:51:35Z","timestamp":1648587095000},"page":"55-71","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"special_numbering":"C","title":["Diagnosis and Management of Rare Cardiomyopathies in Adult and Paediatric Patients. A Position Paper of the Italian Society of Cardiology (SIC) and Italian Society of Paediatric Cardiology (SICP)"],"prefix":"10.1016","volume":"357","author":[{"given":"Giuseppe","family":"Limongelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachele","family":"Adorisio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Baggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Bauce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Biagini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Castelletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Favilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Imazio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Lioncino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Merlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Monda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iacopo","family":"Olivotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanda","family":"Parisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Pelliccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Basso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco","family":"Sinagra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciro","family":"Indolfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camillo","family":"Autore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ijcard.2022.03.050_bb0005","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/eurheartj\/ehm342","article-title":"Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseases","volume":"29","author":"Elliott","year":"2008","journal-title":"Eur. Heart J."},{"issue":"22","key":"10.1016\/j.ijcard.2022.03.050_bb0010","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1016\/j.jacc.2013.08.1644","article-title":"The MOGE(S) classification for a phenotype\u2013genotype nomenclature of cardiomyopathy: endorsed by the World Heart Federation","volume":"62","author":"Arbustini","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"issue":"36","key":"10.1016\/j.ijcard.2022.03.050_bb0015","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.ijcard.2022.03.050_bb0020","first-page":"147","volume":"23","author":"Heidbuchel","year":"2021","journal-title":"EP Eur."},{"issue":"12","key":"10.1016\/j.ijcard.2022.03.050_bb0025","doi-asserted-by":"crossref","first-page":"927","DOI":"10.2459\/JCM.0000000000001050","article-title":"Management of nonischemic-dilated cardiomyopathies in clinical practice: a position paper of the working group on myocardial and pericardial diseases of Italian Society of Cardiology","volume":"21","author":"Merlo","year":"2020","journal-title":"J. Cardiovasc. Med. (Hagerstown)"},{"issue":"7","key":"10.1016\/j.ijcard.2022.03.050_bb0030","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.jacc.2020.12.024","article-title":"Cardiac involvement in Fabry disease: JACC review topic of the week","volume":"77","author":"Pieroni","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.ijcard.2022.03.050_bb0035","first-page":"547","article-title":"Cardiomyopathies and genetic testing in heart failure: role in defining phenotype-targeted approaches and management","volume":"37","author":"Yogasundaram","year":"2021","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.ijcard.2022.03.050_bb0040","series-title":"Prescribing, Dosing and Titrating Exercise in Patients with Hypertrophic Cardiomyopathy for Prevention of Comorbidities: Ready for Prime Time","author":"Cavigli","year":"2020"},{"issue":"12","key":"10.1016\/j.ijcard.2022.03.050_bb0045","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.019610","article-title":"Diagnostic impact of repeated expert review & long-term follow-up in determining etiology of idiopathic cardiac arrest","volume":"10","author":"Merghani","year":"2021","journal-title":"J. Am. Heart Assoc."},{"issue":"12","key":"10.1016\/j.ijcard.2022.03.050_bb0050","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1093\/europace\/euaa232","article-title":"Management of ventricular electrical storm: a contemporary appraisal","volume":"22","author":"Kowlgi","year":"2020","journal-title":"Europace."},{"key":"10.1016\/j.ijcard.2022.03.050_bb0055","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ijcard.2020.01.021","article-title":"Multidisciplinary evaluation and management of obstructive hypertrophic cardiomyopathy in 2020: towards the HCM heart team","volume":"304","author":"Pelliccia","year":"2020","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2022.03.050_bb0060","article-title":"2020 AHA\/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy","volume":"20","author":"Ommen","year":"2020","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ijcard.2022.03.050_bb0065","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/eurheartj\/ehaa605","article-title":"2020 ESC guidelines on sports cardiology and exercise in patients with cardiovascular disease","volume":"42","author":"Pelliccia","year":"2021","journal-title":"Eur. Heart J."},{"issue":"39","key":"10.1016\/j.ijcard.2022.03.050_bb0070","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Zamorano","year":"2014","journal-title":"Eur. Heart J."},{"issue":"7","key":"10.1016\/j.ijcard.2022.03.050_bb0075","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1056\/NEJMra1710575","article-title":"Clinical course and management of hypertrophic cardiomyopathy. Longo DL, ed","volume":"379","author":"Maron","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2022.03.050_bb0080","article-title":"Clinical characteristics and outcomes in childhood-onset hypertrophic cardiomyopathy","volume":"26","author":"Marston","year":"2021","journal-title":"Eur. Heart J."},{"issue":"12","key":"10.1016\/j.ijcard.2022.03.050_bb0085","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1093\/eurheartj\/ehy798","article-title":"Clinical presentation and survival of childhood hypertrophic cardiomyopathy: a retrospective study in United Kingdom","volume":"40","author":"Norrish","year":"2019","journal-title":"Eur. Heart J."},{"issue":"6","key":"10.1016\/j.ijcard.2022.03.050_bb0090","doi-asserted-by":"crossref","first-page":"5057","DOI":"10.1002\/ehf2.13573","article-title":"Clinical presentation and long-term outcomes of infantile hypertrophic cardiomyopathy: a European multicentre study","volume":"8","author":"Norrish","year":"2021","journal-title":"ESC Heart Fail."},{"issue":"19","key":"10.1016\/j.ijcard.2022.03.050_bb0095","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1093\/eurheartj\/ehs397","article-title":"Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC working group on myocardial and pericardial diseases","volume":"34","author":"Rapezzi","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2022.03.050_bb0100","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ijcard.2019.06.073","article-title":"Prevalence and clinical significance of red flags in patients with hypertrophic cardiomyopathy","volume":"299","author":"Limongelli","year":"2020","journal-title":"Int. J. Cardiol."},{"issue":"9646","key":"10.1016\/j.ijcard.2022.03.050_bb0105","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/S0140-6736(08)61555-X","article-title":"Pompe\u2019s disease","volume":"372","author":"van der Ploeg","year":"2008","journal-title":"Lancet."},{"issue":"7","key":"10.1016\/j.ijcard.2022.03.050_bb0110","first-page":"631","article-title":"Glycogen storage diseases presenting as hypertrophic cardiomyopathy","volume":"63","author":"Hirono","year":"2015","journal-title":"Respir. Circ."},{"issue":"11","key":"10.1016\/j.ijcard.2022.03.050_bb0115","first-page":"1360","article-title":"Mitochondrial diseases and cardiomyopathies","volume":"31","author":"Brunel-Guitton","year":"2015","journal-title":"Can. J. Cardiol."},{"issue":"2","key":"10.1016\/j.ijcard.2022.03.050_bb0120","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.amjcard.2006.07.089","article-title":"Cardiac involvement in adults with m.3243A>G MELAS gene mutation","volume":"99","author":"Vydt","year":"2007","journal-title":"Am. J. Cardiol."},{"issue":"24","key":"10.1016\/j.ijcard.2022.03.050_bb0125","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1093\/eurheartj\/ehs275","article-title":"Cardiac involvement in mitochondrial DNA disease: clinical spectrum, diagnosis, and management","volume":"33","author":"Bates","year":"2012","journal-title":"Eur. Heart J."},{"issue":"8","key":"10.1016\/j.ijcard.2022.03.050_bb0130","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1212\/WNL.0b013e3181d0ccf4","article-title":"Cardiac involvement is frequent in patients with the m.8344A>G mutation of mitochondrial DNA","volume":"74","author":"Wahbi","year":"2010","journal-title":"Neurology."},{"issue":"1","key":"10.1016\/j.ijcard.2022.03.050_bb0135","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.111.963900","article-title":"Mitochondrial A3243G mutation with manifestation of acute dilated cardiomyopathy","volume":"5","author":"Stalder","year":"2012","journal-title":"Circ. Heart Fail."},{"issue":"8735","key":"10.1016\/j.ijcard.2022.03.050_bb0140","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/0140-6736(91)92196-9","article-title":"Mitochondrial leucine tRNA mutation in a mitochondrial encephalomyopathy","volume":"337","author":"Ino","year":"1991","journal-title":"Lancet."},{"issue":"1","key":"10.1016\/j.ijcard.2022.03.050_bb0145","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0006-291X(05)80773-9","article-title":"Mitochondrial tRNAlle mutation in fatal cardiomyopathy","volume":"186","author":"Taniike","year":"1992","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.ijcard.2022.03.050_bb0150","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.hfc.2021.07.003","article-title":"Cardiovascular involvement in mtDNA disease: diagnosis, management, and therapeutic options","volume":"18","author":"Lioncino","year":"2022","journal-title":"Heart Fail. Clin."},{"issue":"4","key":"10.1016\/j.ijcard.2022.03.050_bb0155","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/ajmg.a.36982","article-title":"Rapidly progressive hypertrophic cardiomyopathy in an infant with Noonan syndrome with multiple lentigines: palliative treatment with a rapamycin analog","volume":"167","author":"Hahn","year":"2015","journal-title":"Am. J. Med. Genet. Part A"},{"issue":"5","key":"10.1016\/j.ijcard.2022.03.050_bb0160","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/MOP.0000000000000669","article-title":"Cardiovascular disease in Noonan syndrome","volume":"30","author":"Pierpont","year":"2018","journal-title":"Curr. Opin. Pediatr."},{"issue":"2","key":"10.1016\/j.ijcard.2022.03.050_bb0165","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.hfc.2017.12.005","article-title":"Clinical presentation and natural history of hypertrophic cardiomyopathy in RASopathies","volume":"14","author":"Calcagni","year":"2018","journal-title":"Heart Fail. Clin."},{"issue":"0","key":"10.1016\/j.ijcard.2022.03.050_bb0170","article-title":"Hypertrophic cardiomyopathy in RASopathies: diagnosis, clinical characteristics, prognostic implications, and management","volume":"0","author":"Lioncino","year":"2021","journal-title":"Heart Fail. Clin."},{"issue":"4","key":"10.1016\/j.ijcard.2022.03.050_bb0175","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1096-7192(02)00195-6","article-title":"Mutation analysis of the G4.5 gene in patients with isolated left ventricular noncompaction","volume":"77","author":"Chen","year":"2002","journal-title":"Mol. Genet. Metab."},{"issue":"3","key":"10.1016\/j.ijcard.2022.03.050_bb0180","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1651-2227.2004.tb02974.x","article-title":"Barth syndrome without 3-methylglutaconic aciduria","volume":"93","author":"Rahbek Schmidt","year":"2004","journal-title":"Acta Paediatr. Int. J. Paediatr."},{"issue":"9","key":"10.1016\/j.ijcard.2022.03.050_bb0185","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/gim.2014.177","article-title":"Diagnosis and management of mitochondrial disease: a consensus statement from the mitochondrial medicine society","volume":"17","author":"Parikh","year":"2015","journal-title":"Genet. Med."},{"issue":"1","key":"10.1016\/j.ijcard.2022.03.050_bb0190","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ajmg.c.31765","article-title":"Congenital heart defects in Noonan syndrome: diagnosis, management, and treatment","volume":"184","author":"Linglart","year":"2020","journal-title":"Am. J. Med. Genet. Part C Semin. Med. Genet."},{"issue":"9863","key":"10.1016\/j.ijcard.2022.03.050_bb0195","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0140-6736(12)61023-X","article-title":"Noonan syndrome","volume":"381","author":"Roberts","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2022.03.050_bb0200","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ijcard.2017.07.068","article-title":"Cardiac defects, morbidity and mortality in patients affected by RASopathies. CARNET study results","volume":"245","author":"Calcagni","year":"2017","journal-title":"Int. J. Cardiol."},{"issue":"10","key":"10.1016\/j.ijcard.2022.03.050_bb0205","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/bdr2.1670","article-title":"Atypical cardiac defects in patients with RASopathies: updated data on CARNET study","volume":"112","author":"Calcagni","year":"2020","journal-title":"Birth Defects Res."},{"issue":"11","key":"10.1016\/j.ijcard.2022.03.050_bb0210","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1001\/archneur.64.11.1625","article-title":"Wolff-Parkinson-white syndrome in patients with MELAS","volume":"64","author":"Sproule","year":"2007","journal-title":"Arch. Neurol."},{"issue":"42","key":"10.1016\/j.ijcard.2022.03.050_bb0215","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1093\/eurheartj\/ehv307","article-title":"Long-term cardiac prognosis and risk stratification in 260 adults presenting with mitochondrial diseases","volume":"36","author":"Wahbi","year":"2015","journal-title":"Eur. Heart J."},{"issue":"4","key":"10.1016\/j.ijcard.2022.03.050_bb0220","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1161\/01.CIR.91.4.955","article-title":"Cardiac involvement in mitochondrial diseases","volume":"91","author":"Anan","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2022.03.050_bb0225","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2261-2-12","article-title":"Cardiac abnormalities in patients with mitochondrial DNA mutation 3243A>G","volume":"2","author":"Majamaa-Voltti","year":"2002","journal-title":"BMC Cardiovasc. Disord."},{"issue":"7","key":"10.1016\/j.ijcard.2022.03.050_bb0230","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1136\/heart.89.7.791","article-title":"Cardiac abnormalities in patients with Leber\u2019s hereditary optic neuropathy","volume":"89","author":"Sorajja","year":"2003","journal-title":"Heart"},{"issue":"5","key":"10.1016\/j.ijcard.2022.03.050_bb0235","first-page":"622","article-title":"Electrophysiological mechanism of the short PR interval in Pompe disease","volume":"128","author":"Gillette","year":"1974","journal-title":"Am. J. Dis. Child."},{"issue":"5","key":"10.1016\/j.ijcard.2022.03.050_bb0240","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/01.gim.0000195896.04069.5f","article-title":"Electrocardiographic response to enzyme replacement therapy for Pompe disease","volume":"8","author":"Ansong","year":"2006","journal-title":"Genet. Med."},{"issue":"2","key":"10.1016\/j.ijcard.2022.03.050_bb0245","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/0002-8703(78)90093-5","article-title":"Pompe\u2019s disease presenting as hypertrophic myocardiopathy with Wolff-Parkinson-white syndrome","volume":"96","author":"Bulkley","year":"1978","journal-title":"Am. Heart J."},{"issue":"5","key":"10.1016\/j.ijcard.2022.03.050_bb0250","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1161\/CIRCGENETICS.108.821314","article-title":"Prevalence of sarcomere protein gene mutations in preadolescent children with hypertrophic cardiomyopathy","volume":"2","author":"Kaski","year":"2009","journal-title":"Circ. Cardiovasc. Genet."},{"issue":"39","key":"10.1016\/j.ijcard.2022.03.050_bb0255","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Zamorano","year":"2014","journal-title":"Eur. Heart J."},{"issue":"6","key":"10.1016\/j.ijcard.2022.03.050_bb0260","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1161\/CIRCULATIONAHA.106.621185","article-title":"Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children: findings from the Pediatric cardiomyopathy registry","volume":"115","author":"Colan","year":"2007","journal-title":"Circulation"},{"issue":"9908","key":"10.1016\/j.ijcard.2022.03.050_bb0265","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1016\/S0140-6736(13)61685-2","article-title":"Risk stratifi cation at diagnosis for children with hypertrophic cardiomyopathy: an analysis of data from the Pediatric cardiomyopathy registry","volume":"382","author":"Lipshultz","year":"2013","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ijcard.2022.03.050_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2005.11.033","article-title":"A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease","volume":"148","author":"Kishnani","year":"2006","journal-title":"J. Pediatr."},{"issue":"6","key":"10.1016\/j.ijcard.2022.03.050_bb0275","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/GIM.0b013e31820ad795","article-title":"Natural history of Danon disease","volume":"13","author":"Boucek","year":"2011","journal-title":"Genet. Med."},{"issue":"6","key":"10.1016\/j.ijcard.2022.03.050_bb0280","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1161\/CIRCGEN.120.003117","article-title":"Clinical profile of cardiac involvement in Danon disease: a multicenter European registry","volume":"13","author":"Lotan","year":"2020","journal-title":"Circ. Genomic Precis. Med."},{"issue":"5","key":"10.1016\/j.ijcard.2022.03.050_bb0285","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s10545-016-9932-2","article-title":"Glycogen storage disease type III: diagnosis, genotype, management, clinical course and outcome","volume":"39","author":"Sentner","year":"2016","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.ijcard.2022.03.050_bb0290","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.115.003121","article-title":"Clinical spectrum of PRKAG2 syndrome","volume":"9","author":"Porto","year":"2016","journal-title":"Circ. Arrhythm. Electrophysiol."},{"issue":"1","key":"10.1016\/j.ijcard.2022.03.050_bb0295","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.hfc.2021.07.005","article-title":"Diagnosis and management of cardiovascular involvement in Fabry disease","volume":"18","author":"Rubino","year":"2022","journal-title":"Heart Fail. Clin."},{"issue":"7","key":"10.1016\/j.ijcard.2022.03.050_bb0300","first-page":"631","article-title":"Glycogen storage diseases presenting as hypertrophic cardiomyopathy","volume":"63","author":"Hirono","year":"2015","journal-title":"Respir. Circ."},{"issue":"4","key":"10.1016\/j.ijcard.2022.03.050_bb0305","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.111.968917","article-title":"Rare forms of preexcitation a case study and brief overview of familial forms of preexcitation","volume":"5","author":"Koneru","year":"2012","journal-title":"Circ. Arrhythm. Electrophysiol."},{"issue":"16","key":"10.1016\/j.ijcard.2022.03.050_bb0310","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1056\/NEJM199610173351601","article-title":"Clinical and genetic abnormalities in patients with Friedreich\u2019s ataxia","volume":"335","author":"D\u00fcrr","year":"1996","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ijcard.2022.03.050_bb0315","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.hfc.2021.07.001","article-title":"Diagnosis and management of cardiovascular involvement in Friedreich ataxia","volume":"18","author":"Monda","year":"2022","journal-title":"Heart Fail. Clin."},{"key":"10.1016\/j.ijcard.2022.03.050_bb0320","article-title":"Friedreich\u2019s ataxia-associated childhood hypertrophic cardiomyopathy: a national cohort study","author":"Norrish","year":"2021","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.ijcard.2022.03.050_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2022.03.013","article-title":"Bisoprolol for treatment of symptomatic patients with obstructive hypertrophic cardiomyopathy. The BASIC (bisoprolol AS therapy in hypertrophic cardiomyopathy) study","author":"Monda","year":"2022","journal-title":"Int. J. Cardiol."},{"issue":"1","key":"10.1016\/j.ijcard.2022.03.050_bb0330","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.hfc.2021.07.006","article-title":"Cardiovascular involvement in transthyretin cardiac amyloidosis","volume":"18","author":"Lioncino","year":"2022","journal-title":"Heart Fail. Clin."},{"issue":"3","key":"10.1016\/j.ijcard.2022.03.050_bb0335","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1080\/07853890701842988","article-title":"Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation in alpha2-macroglobulin and tau: a population-based autopsy study","volume":"40","author":"Tanskanen","year":"2008","journal-title":"Ann. Med."},{"issue":"24","key":"10.1016\/j.ijcard.2022.03.050_bb0340","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy diagnosis of cardiac transthyretin amyloidosis","volume":"133","author":"Gillmore","year":"2016","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.ijcard.2022.03.050_bb0345","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1001\/jamacardio.2016.2839","article-title":"Multicenter study of planar technetium 99m pyrophosphate cardiac imaging: predicting survival for patients with ATTR cardiac amyloidosis","volume":"1","author":"Castano","year":"2016","journal-title":"JAMA Cardiol."},{"issue":"38","key":"10.1016\/j.ijcard.2022.03.050_bb0350","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1093\/eurheartj\/ehx350","article-title":"Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement","volume":"38","author":"Castano","year":"2017","journal-title":"Eur. Heart J."},{"issue":"38","key":"10.1016\/j.ijcard.2022.03.050_bb0355","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1093\/eurheartj\/ehv338","article-title":"Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction","volume":"36","author":"Gonz\u00e1lez-L\u00f3pez","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2022.03.050_bb0360","article-title":"Unveiling outcomes in coexisting severe aortic stenosis and transthyretin cardiac amyloidosis","author":"Rosenblum","year":"2020","journal-title":"Eur. J. Heart Fail."},{"issue":"23","key":"10.1016\/j.ijcard.2022.03.050_bb0365","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1093\/eurheartj\/ehv583","article-title":"Prevalence and clinical phenotype of hereditary transthyretin amyloid cardiomyopathy in patients with increased left ventricular wall thickness","volume":"37","author":"Damy","year":"2016","journal-title":"Eur. Heart J."},{"issue":"9","key":"10.1016\/j.ijcard.2022.03.050_bb0370","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1161\/01.CIR.0000139847.74101.03","article-title":"Prevalence of Fabry disease in female patients with late-onset hypertrophic cardiomyopathy","volume":"110","author":"Chimenti","year":"2004","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.ijcard.2022.03.050_bb0375","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1161\/01.CIR.0000012626.81324.38","article-title":"Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy","volume":"105","author":"Sachdev","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2022.03.050_bb0380","article-title":"66 Prevalence of fabry disease among patients diagnosed hypertrophic cardiomyopathy and unexplained left ventricular hypertrophy in ST. James Hospital (2013\u20132015)","volume":"102","author":"Sulaiman","year":"2016","journal-title":"Heart"},{"issue":"1","key":"10.1016\/j.ijcard.2022.03.050_bb0385","doi-asserted-by":"crossref","first-page":"E7","DOI":"10.1161\/CIR.0000000000000792","article-title":"Cardiac amyloidosis: evolving diagnosis and management: a scientific statement from the American Heart Association","volume":"142","author":"Kittleson","year":"2020","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ijcard.2022.03.050_bb0390","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.jcmg.2019.10.011","article-title":"Multiparametric echocardiography scores for the diagnosis of cardiac amyloidosis","volume":"13","author":"Boldrini","year":"2020","journal-title":"JACC Cardiovasc. Imaging"},{"issue":"3","key":"10.1016\/j.ijcard.2022.03.050_bb0395","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.119.010171","article-title":"Myocardial edema, myocyte injury, and disease severity in Fabry disease","volume":"13","author":"Augusto","year":"2020","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"10.1016\/j.ijcard.2022.03.050_bb0400","article-title":"The myocardial phenotype of Fabry disease pre-hypertrophy and pre-detectable storage","volume":"8","author":"Augusto","year":"2020","journal-title":"Eur. Heart J."},{"issue":"7","key":"10.1016\/j.ijcard.2022.03.050_bb0405","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.119.008872","article-title":"Quantitative myocardial perfusion in Fabry disease","volume":"12","author":"Knott","year":"2019","journal-title":"Circ. Cardiovasc. Imaging"},{"issue":"1","key":"10.1016\/j.ijcard.2022.03.050_bb0410","doi-asserted-by":"crossref","DOI":"10.1186\/s12968-019-0557-0","article-title":"Loss of base-to-apex circumferential strain gradient assessed by cardiovascular magnetic resonance in Fabry disease: relationship to T1 mapping, late gadolinium enhancement and hypertrophy","volume":"21","author":"Mathur","year":"2019","journal-title":"J. Cardiovasc. Magn. Reson."},{"issue":"2","key":"10.1016\/j.ijcard.2022.03.050_bb0415","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1161\/01.CIR.0000152819.97857.9D","article-title":"Cardiovascular magnetic resonance in cardiac amyloidosis","volume":"111","author":"Maceira","year":"2005","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.ijcard.2022.03.050_bb0420","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jacc.2007.10.049","article-title":"Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis. Noninvasive imaging compared to endomyocardial biopsy","volume":"51","author":"Vogelsberg","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.ijcard.2022.03.050_bb0425","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jcmg.2018.02.006","article-title":"Native T1 and extracellular volume in transthyretin amyloidosis","volume":"12","author":"Martinez-Naharro","year":"2019","journal-title":"JACC Cardiovasc. Imaging"},{"issue":"1","key":"10.1016\/j.ijcard.2022.03.050_bb0430","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.hfc.2021.07.014","article-title":"The role of new imaging technologies in the diagnosis of cardiac amyloidosis","volume":"18","author":"Palmiero","year":"2022","journal-title":"Heart Fail. Clin."},{"key":"10.1016\/j.ijcard.2022.03.050_bb0435","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ijcard.2021.07.035","article-title":"External validation of the increased wall thickness score for the diagnosis of cardiac amyloidosis","volume":"339","author":"Monda","year":"2021","journal-title":"Int. J. Cardiol."},{"issue":"3","key":"10.1016\/j.ijcard.2022.03.050_bb0440","doi-asserted-by":"crossref","first-page":"868","DOI":"10.3390\/jcm11030868","article-title":"Multimodality imaging in cardiomyopathies with hypertrophic phenotypes","volume":"11","author":"Monda","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ijcard.2022.03.050_bb0445","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1172-5-30","article-title":"Fabry disease","volume":"5","author":"Germain","year":"2010","journal-title":"Orphanet J. Rare Dis."},{"issue":"4","key":"10.1016\/j.ijcard.2022.03.050_bb0450","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.ymgme.2018.02.014","article-title":"Fabry disease revisited: management and treatment recommendations for adult patients","volume":"123","author":"Ortiz","year":"2018","journal-title":"Mol. Genet. Metab."},{"issue":"15","key":"10.1016\/j.ijcard.2022.03.050_bb0455","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1001\/jama.296.15.1867","article-title":"Incidence, causes, and outcomes of dilated cardiomyopathy in children","volume":"296","author":"Towbin","year":"2006","journal-title":"JAMA"},{"issue":"17","key":"10.1016\/j.ijcard.2022.03.050_bb0460","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/0002-9149(92)90901-A","article-title":"Prevalence and etiology of idiopathic dilated cardiomyopathy (summary of a National Heart, Lung, and Blood Institute workshop)","volume":"69","author":"Manolio","year":"1992","journal-title":"Am. J. Cardiol."},{"issue":"2","key":"10.1016\/j.ijcard.2022.03.050_bb0465","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/ejhf.1103","article-title":"Evolving concepts in dilated cardiomyopathy","volume":"20","author":"Merlo","year":"2018","journal-title":"Eur. J. Heart Fail."},{"issue":"7","key":"10.1016\/j.ijcard.2022.03.050_bb0470","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003450","article-title":"Natural history of dilated cardiomyopathy in children","volume":"5","author":"Puggia","year":"2016","journal-title":"J. Am. Heart Assoc."},{"issue":"8","key":"10.1016\/j.ijcard.2022.03.050_bb0475","doi-asserted-by":"crossref","DOI":"10.1007\/s11936-019-0739-y","article-title":"An update on pediatric cardiomyopathy","volume":"21","author":"Choudhry","year":"2019","journal-title":"Curr. Treat Options Cardiovasc. Med."},{"key":"10.1016\/j.ijcard.2022.03.050_bb0480","series-title":"The Registry of the International Society for Heart and Lung Transplantation: Twentieth Pediatric Heart Transplantation report-2017; Focus Theme: Allograft Ischemic Time","author":"Rossano","year":"2017"},{"issue":"8","key":"10.1016\/j.ijcard.2022.03.050_bb0485","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.amjcard.2005.10.065","article-title":"Incidence and risk distribution of heart failure in adolescents and adults with congenital heart disease after cardiac surgery","volume":"97","author":"Norozi","year":"2006","journal-title":"Am. J. Cardiol."},{"issue":"9","key":"10.1016\/j.ijcard.2022.03.050_bb0490","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1093\/eurjhf\/hfq093","article-title":"Prognostic impact of familial screening in dilated cardiomyopathy","volume":"12","author":"Moretti","year":"2010","journal-title":"Eur. J. Heart Fail."},{"issue":"21","key":"10.1016\/j.ijcard.2022.03.050_bb0495","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1016\/j.jacc.2017.09.1089","article-title":"Survival without cardiac transplantation among children with dilated cardiomyopathy","volume":"70","author":"Singh","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"issue":"14","key":"10.1016\/j.ijcard.2022.03.050_bb0500","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.94382","article-title":"Pediatric and adult dilated cardiomyopathy represent distinct pathological entities","volume":"2","author":"Patel","year":"2017","journal-title":"JCI Insight"},{"issue":"7","key":"10.1016\/j.ijcard.2022.03.050_bb0505","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1056\/NEJMoa1110186","article-title":"Truncations of titin causing dilated cardiomyopathy","volume":"366","author":"Herman","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.ijcard.2022.03.050_bb0510","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/ejhf.673","article-title":"Truncating titin mutations are associated with a mild and treatable form of dilated cardiomyopathy","volume":"19","author":"Jansweijer","year":"2017","journal-title":"Eur. J. Heart Fail."},{"issue":"18","key":"10.1016\/j.ijcard.2022.03.050_bb0515","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1016\/j.jacc.2017.08.063","article-title":"Phenotype and clinical outcomes of titin cardiomyopathy","volume":"70","author":"Tayal","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"issue":"7","key":"10.1016\/j.ijcard.2022.03.050_bb0520","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1161\/CIRCRESAHA.116.309386","article-title":"Pediatric cardiomyopathies","volume":"121","author":"Lee","year":"2017","journal-title":"Circ. Res."},{"issue":"13","key":"10.1016\/j.ijcard.2022.03.050_bb0525","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1161\/CIR.0000000000000526","article-title":"Management of cardiac involvement associated with neuromuscular diseases: a scientific statement from the American Heart Association","volume":"136","author":"Feingold","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2022.03.050_bb0530","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fcvm.2016.00025","article-title":"Mitochondrial cardiomyopathies","volume":"3","author":"El-Hattab","year":"2016","journal-title":"Front. Cardiovasc. Med."},{"issue":"6","key":"10.1016\/j.ijcard.2022.03.050_bb0535","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.jtcvs.2016.06.066","article-title":"Expert consensus guidelines: anomalous aortic origin of a coronary artery","volume":"153","author":"Brothers","year":"2017","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"9","key":"10.1016\/j.ijcard.2022.03.050_bb0540","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.mayocp.2016.05.013","article-title":"Myocarditis in clinical practice","volume":"91","author":"Sinagra","year":"2016","journal-title":"Mayo Clin. Proc."},{"issue":"1","key":"10.1016\/j.ijcard.2022.03.050_bb0545","doi-asserted-by":"crossref","first-page":"E9","DOI":"10.1161\/CIR.0000000000000682","article-title":"Cardiomyopathy in children: classification and diagnosis: a scientific statement from the American Heart Association","volume":"140","author":"Lipshultz","year":"2019","journal-title":"Circulation."},{"issue":"5","key":"10.1016\/j.ijcard.2022.03.050_bb0550","doi-asserted-by":"crossref","DOI":"10.3390\/biom11050696","article-title":"Troponin T mutation as a cause of left ventricular systolic dysfunction in a young patient with previous surgical correction of aortic coarctation","volume":"11","author":"Caiazza","year":"2021","journal-title":"Biomolecules."},{"issue":"12","key":"10.1016\/j.ijcard.2022.03.050_bb0555","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.jacc.2015.07.023","article-title":"Prognostic relevance of gene-environment interactions in patients with dilated cardiomyopathy: applying the MOGE(S) classification","volume":"66","author":"Hazebroek","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.ijcard.2022.03.050_bb0560","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cardfail.2009.01.006","article-title":"Genetic evaluation of cardiomyopathy\u2013a Heart Failure Society of America practice guideline","volume":"15","author":"Hershberger","year":"2009","journal-title":"J. Card. Fail."},{"issue":"23","key":"10.1016\/j.ijcard.2022.03.050_bb0565","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1161\/CIRCULATIONAHA.119.044934","article-title":"Desmoplakin cardiomyopathy, a fibrotic and inflammatory form of cardiomyopathy distinct from typical dilated or Arrhythmogenic right ventricular cardiomyopathy","volume":"141","author":"Smith","year":"2020","journal-title":"Circulation."},{"issue":"7","key":"10.1016\/j.ijcard.2022.03.050_bb0570","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/j.jcmg.2020.07.028","article-title":"Inflammatory episodes of Desmoplakin cardiomyopathy masquerading as myocarditis: unique features on cardiac magnetic resonance imaging","volume":"14","author":"Alley","year":"2021","journal-title":"JACC Cardiovasc. Imaging"},{"issue":"22","key":"10.1016\/j.ijcard.2022.03.050_bb0575","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1016\/j.jacc.2016.09.927","article-title":"Truncating FLNC mutations are associated with high-risk dilated and Arrhythmogenic cardiomyopathies","volume":"68","author":"Ortiz-Genga","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"issue":"11","key":"10.1016\/j.ijcard.2022.03.050_bb0580","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.jacc.2019.06.072","article-title":"Genetic risk of arrhythmic phenotypes in patients with dilated cardiomyopathy","volume":"74","author":"Gigli","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"issue":"10","key":"10.1016\/j.ijcard.2022.03.050_bb0585","doi-asserted-by":"crossref","DOI":"10.1007\/s11886-018-1030-7","article-title":"Genetics of dilated cardiomyopathy: clinical implications","volume":"20","author":"Paldino","year":"2018","journal-title":"Curr. Cardiol. Rep."},{"issue":"3","key":"10.1016\/j.ijcard.2022.03.050_bb0590","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3390\/cells5030033","article-title":"Skeletal muscle laminopathies: a review of clinical and molecular features","volume":"5","author":"Maggi","year":"2016","journal-title":"Cells."},{"issue":"15","key":"10.1016\/j.ijcard.2022.03.050_bb0595","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.jacc.2008.06.044","article-title":"Long-term outcome and risk stratification in dilated cardiolaminopathies","volume":"52","author":"Pasotti","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.ijcard.2022.03.050_bb0600","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1093\/eurjhf\/hfs191","article-title":"Gender-specific differences in major cardiac events and mortality in lamin A\/C mutation carriers","volume":"15","author":"van Rijsingen","year":"2013","journal-title":"Eur. J. Heart Fail."},{"issue":"29","key":"10.1016\/j.ijcard.2022.03.050_bb0605","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1093\/eurheartj\/ehab294","article-title":"Prediction of ventricular arrhythmia in phospholamban p.Arg14del mutation carriers\u2013reaching the frontiers of individual risk prediction","volume":"42","author":"Verstraelen","year":"2021","journal-title":"Eur. Heart J."},{"issue":"6","key":"10.1016\/j.ijcard.2022.03.050_bb0610","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.amjcard.2016.05.063","article-title":"Characterization and long-term prognosis of postmyocarditic dilated cardiomyopathy compared with idiopathic dilated cardiomyopathy","volume":"118","author":"Merlo","year":"2016","journal-title":"Am. J. Cardiol."},{"issue":"3","key":"10.1016\/j.ijcard.2022.03.050_bb0615","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0214616","article-title":"Persistent left ventricular dysfunction after acute lymphocytic myocarditis: frequency and predictors","volume":"14","author":"Merlo","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcard.2022.03.050_bb0620","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/978-3-030-35276-9_4","article-title":"Genetic basis of myocarditis: myth or reality?","author":"Arbustini","year":"2020","journal-title":"Myocarditis"},{"issue":"Suppl B","key":"10.1016\/j.ijcard.2022.03.050_bb0625","doi-asserted-by":"crossref","first-page":"B90","DOI":"10.1093\/eurheartj\/suz033","article-title":"Myocarditis evolving in cardiomyopathy: when genetics and offending causes work together","volume":"21","author":"Cannata","year":"2019","journal-title":"Eur. Heart J. Suppl."},{"key":"10.1016\/j.ijcard.2022.03.050_bb0630","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/eht210","article-title":"Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on myocardial and pericardial diseases","author":"Caforio","year":"2013","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.ijcard.2022.03.050_bb0635","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jacc.2019.11.014","article-title":"Peripartum cardiomyopathy: JACC state-of-the-art review","volume":"75","author":"Davis","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.ijcard.2022.03.050_bb0640","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa1505517","article-title":"Shared genetic predisposition in Peripartum and dilated cardiomyopathies","volume":"374","author":"Ware","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"20","key":"10.1016\/j.ijcard.2022.03.050_bb0645","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1161\/CIRCULATIONAHA.111.050773","article-title":"Iron overload cardiomyopathy in clinical practice","volume":"124","author":"Kremastinos","year":"2011","journal-title":"Circulation."},{"key":"10.1016\/j.ijcard.2022.03.050_bb0650","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002149","article-title":"Arrhythmogenic phenotype in dilated cardiomyopathy: natural history and predictors of life-threatening arrhythmias","author":"Spezzacatene","year":"2015","journal-title":"J. Am. Heart Assoc."},{"issue":"11","key":"10.1016\/j.ijcard.2022.03.050_bb0655","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1136\/hrt.2007.134684","article-title":"Idiopathic restrictive cardiomyopathy in children is caused by mutations in cardiac sarcomere protein genes","volume":"94","author":"Kaski","year":"2008","journal-title":"Heart."},{"issue":"2","key":"10.1016\/j.ijcard.2022.03.050_bb0660","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI200316336","article-title":"Idiopathic restrictive cardiomyopathy is part of the clinical expression of cardiac troponin I mutations","volume":"111","author":"Mogensen","year":"2003","journal-title":"J. Clin. Invest."},{"issue":"1\u20132","key":"10.1016\/j.ijcard.2022.03.050_bb0665","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s11010-009-0157-7","article-title":"Genetic and clinical profile of Indian patients of idiopathic restrictive cardiomyopathy with and without hypertrophy","volume":"331","author":"Rai","year":"2009","journal-title":"Mol. Cell. Biochem."},{"issue":"5","key":"10.1016\/j.ijcard.2022.03.050_bb0670","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ejheart.2005.11.003","article-title":"Desmin accumulation restrictive cardiomyopathy and atrioventricular block associated with desmin gene defects","volume":"8","author":"Arbustini","year":"2006","journal-title":"Eur. J. Heart Fail."},{"issue":"3","key":"10.1016\/j.ijcard.2022.03.050_bb0675","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.nmd.2011.10.019","article-title":"High cardiovascular morbidity and mortality in myofibrillar myopathies due to DES gene mutations: a 10-year longitudinal study","volume":"22","author":"Wahbi","year":"2012","journal-title":"Neuromuscul. Disord."},{"issue":"4","key":"10.1016\/j.ijcard.2022.03.050_bb0680","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1034\/j.1399-0004.2001.590406.x","article-title":"Clinical and molecular studies of a large family with desmin-associated restrictive cardiomyopathy","volume":"59","author":"Zhang","year":"2001","journal-title":"Clin. Genet."},{"issue":"3","key":"10.1016\/j.ijcard.2022.03.050_bb0685","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/humu.22942","article-title":"Mutations in FLNC are associated with familial restrictive cardiomyopathy","volume":"37","author":"Brodehl","year":"2016","journal-title":"Hum. Mutat."},{"issue":"5","key":"10.1016\/j.ijcard.2022.03.050_bb0690","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s10741-019-09848-4","article-title":"Endomyocardial fibrosis: past, present, and future","volume":"25","author":"Duraes","year":"2020","journal-title":"Heart Fail. Rev."},{"issue":"10","key":"10.1016\/j.ijcard.2022.03.050_bb0695","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.jacc.2018.01.017","article-title":"Spectrum of restrictive and infiltrative cardiomyopathies: part 2 of a 2-part series","volume":"71","author":"Pereira","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2022.03.050_bb0700","doi-asserted-by":"crossref","DOI":"10.1161\/01.CIR.102.8.876","article-title":"Sudden death and cardiovascular collapse in children with restrictive cardiomyopathy","author":"Rivenes","year":"2000","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ijcard.2022.03.050_bb0705","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1161\/CIRCHEARTFAILURE.111.964395","article-title":"Conduction abnormalities in pediatric patients with restrictive cardiomyopathy","volume":"5","author":"Walsh","year":"2012","journal-title":"Circ. Heart Fail."},{"issue":"1","key":"10.1016\/j.ijcard.2022.03.050_bb0710","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF00877096","article-title":"Iron overload cardiomyopathies: new insights into an old disease","volume":"8","author":"Liu","year":"1994","journal-title":"Cardiovasc. Drugs Ther."},{"issue":"3","key":"10.1016\/j.ijcard.2022.03.050_bb0715","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/HCO.0000000000000511","article-title":"Iron overload cardiomyopathy: from diagnosis to management","volume":"33","author":"D\u00edez-L\u00f3pez","year":"2018","journal-title":"Curr. Opin. Cardiol."},{"issue":"11","key":"10.1016\/j.ijcard.2022.03.050_bb0720","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.cardfail.2010.05.009","article-title":"Iron-overload cardiomyopathy: pathophysiology, diagnosis, and treatment","volume":"16","author":"Murphy","year":"2010","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.ijcard.2022.03.050_bb0725","first-page":"1","article-title":"The right heart","volume":"9781447123989","author":"Gaine","year":"2014","journal-title":"Right Heart"},{"issue":"3","key":"10.1016\/j.ijcard.2022.03.050_bb0730","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJM198801213180301","article-title":"Right ventricular cardiomyopathy and sudden death in young people","volume":"318","author":"Thiene","year":"1988","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.ijcard.2022.03.050_bb0735","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1161\/CIRCRESAHA.117.309345","article-title":"Arrhythmogenic cardiomyopathy","volume":"121","author":"Corrado","year":"2017","journal-title":"Circ. Res."},{"issue":"7","key":"10.1016\/j.ijcard.2022.03.050_bb0740","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1016\/S0735-1097(00)00997-9","article-title":"Clinical profile and long-term follow-up of 37 families with arrhythmogenic right ventricular cardiomyopathy","volume":"36","author":"Nava","year":"2000","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.ijcard.2022.03.050_bb0745","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13023-016-0407-1","article-title":"Arrhythmogenic cardiomyopathy","volume":"11","author":"Pilichou","year":"2016","journal-title":"Orphanet J. Rare Dis."},{"issue":"3","key":"10.1016\/j.ijcard.2022.03.050_bb0750","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S1054-8807(01)00067-9","article-title":"Arrhythmogenic right ventricular cardiomyopathy: an update","volume":"10","author":"Thiene","year":"2001","journal-title":"Cardiovasc. Pathol."},{"issue":"25","key":"10.1016\/j.ijcard.2022.03.050_bb0755","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1016\/j.jacc.2008.09.019","article-title":"Left-dominant arrhythmogenic cardiomyopathy: an under-recognized clinical entity","volume":"52","author":"Sen-Chowdhry","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"issue":"22","key":"10.1016\/j.ijcard.2022.03.050_bb0760","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1093\/eurheartj\/ehn415","article-title":"Quantitative assessment of endomyocardial biopsy in arrhythmogenic right ventricular cardiomyopathy\/dysplasia: an in vitro validation of diagnostic criteria","volume":"29","author":"Basso","year":"2008","journal-title":"Eur. Heart J."},{"issue":"5","key":"10.1016\/j.ijcard.2022.03.050_bb0765","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/0002-9343(90)90176-E","article-title":"Sudden death in young competitive athletes: clinicopathologic correlations in 22 cases","volume":"89","author":"Corrado","year":"1990","journal-title":"Am. J. Med."},{"issue":"11","key":"10.1016\/j.ijcard.2022.03.050_bb0770","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1016\/j.jacc.2003.03.002","article-title":"Does sports activity enhance the risk of sudden death in adolescents and young adults?","volume":"42","author":"Corrado","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.ijcard.2022.03.050_bb0775","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1093\/europace\/euaa343","article-title":"\u201cHot phase\u201d clinical presentation in arrhythmogenic cardiomyopathy","volume":"23","author":"Bariani","year":"2021","journal-title":"Europace."},{"issue":"18","key":"10.1016\/j.ijcard.2022.03.050_bb0780","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21186462","article-title":"Molecular basis of inflammation in the pathogenesis of cardiomyopathies","volume":"21","author":"Monda","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.ijcard.2022.03.050_bb0785","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/HCO.0000000000000509","article-title":"Genetic basis of arrhythmogenic cardiomyopathy","volume":"33","author":"Karmouch","year":"2018","journal-title":"Curr. Opin. Cardiol."},{"issue":"1","key":"10.1016\/j.ijcard.2022.03.050_bb0790","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.hrthm.2009.09.070","article-title":"Multiple mutations in desmosomal proteins encoding genes in arrhythmogenic right ventricular cardiomyopathy\/dysplasia","volume":"7","author":"Bauce","year":"2010","journal-title":"Heart Rhythm."},{"issue":"6","key":"10.1016\/j.ijcard.2022.03.050_bb0795","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1161\/CIRCGENETICS.113.000288","article-title":"Compound and digenic heterozygosity predicts lifetime arrhythmic outcome and sudden cardiac death in desmosomal gene-related arrhythmogenic right ventricular cardiomyopathy","volume":"6","author":"Rigato","year":"2013","journal-title":"Circ. Cardiovasc. Genet."},{"issue":"13","key":"10.1016\/j.ijcard.2022.03.050_bb0800","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1161\/CIRCULATIONAHA.108.840827","article-title":"Diagnosis of arrhythmogenic right ventricular cardiomyopathy\/dysplasia: proposed modification of the task force criteria","volume":"121","author":"Marcus","year":"2010","journal-title":"Circulation."},{"issue":"8","key":"10.1016\/j.ijcard.2022.03.050_bb0805","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/ejhf.1534","article-title":"Definition and treatment of arrhythmogenic cardiomyopathy: an updated expert panel report","volume":"21","author":"Elliott","year":"2019","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2022.03.050_bb0810","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ijcard.2020.06.005","article-title":"Diagnosis of arrhythmogenic cardiomyopathy: the Padua criteria","volume":"319","author":"Corrado","year":"2020","journal-title":"Int. J. Cardiol."},{"issue":"1","key":"10.1016\/j.ijcard.2022.03.050_bb0815","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12968-014-0050-8","article-title":"Arrhythmogenic right ventricular cardiomyopathy (ARVC): cardiovascular magnetic resonance update","volume":"16","author":"Te Riele","year":"2014","journal-title":"J. Cardiovasc. Magn. Reson."},{"issue":"14","key":"10.1016\/j.ijcard.2022.03.050_bb0820","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1093\/eurheartj\/ehz669","article-title":"Arrhythmogenic right ventricular cardiomyopathy: evaluation of the current diagnostic criteria and differential diagnosis","volume":"41","author":"Corrado","year":"2020","journal-title":"Eur. Heart J."},{"issue":"5","key":"10.1016\/j.ijcard.2022.03.050_bb0825","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1161\/CIRCULATIONAHA.115.017944","article-title":"Treatment of Arrhythmogenic right ventricular cardiomyopathy\/dysplasia: an international task force consensus statement","volume":"132","author":"Corrado","year":"2015","journal-title":"Circulation."},{"issue":"11","key":"10.1016\/j.ijcard.2022.03.050_bb0830","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1016\/j.hrthm.2011.06.026","article-title":"Clinical phenotype and diagnosis of arrhythmogenic right ventricular cardiomyopathy in pediatric patients carrying desmosomal gene mutations","volume":"8","author":"Bauce","year":"2011","journal-title":"Heart Rhythm."},{"issue":"6","key":"10.1016\/j.ijcard.2022.03.050_bb0835","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.jacep.2015.08.004","article-title":"Arrhythmogenic right ventricular dysplasia\/cardiomyopathy in the pediatric population: clinical characterization and comparison with adult-onset disease","volume":"1","author":"Te Riele","year":"2015","journal-title":"JACC Clin. Electrophysiol."},{"issue":"4","key":"10.1016\/j.ijcard.2022.03.050_bb0840","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/hrt.56.4.321","article-title":"Cardiac abnormalities in familial palmoplantar keratosis","volume":"56","author":"Protonotarios","year":"1986","journal-title":"Br. Heart J."},{"issue":"18","key":"10.1016\/j.ijcard.2022.03.050_bb0845","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1093\/hmg\/9.18.2761","article-title":"Recessive mutation in desmoplakin disrupts desmoplakin-intermediate filament interactions and causes dilated cardiomyopathy, woolly hair and keratoderma","volume":"9","author":"Norgett","year":"2000","journal-title":"Hum. Mol. Genet."},{"issue":"4","key":"10.1016\/j.ijcard.2022.03.050_bb0850","article-title":"ATS\/ERS\/WASOG statement on sarcoidosis. Sarcoidosis statement committee. American Thoracic Society. European Respiratory Society. World Association for Sarcoidosis and Other Granulomatous Disorders","volume":"14","author":"Costabel","year":"1999","journal-title":"Eur. Respir. J."},{"issue":"7","key":"10.1016\/j.ijcard.2022.03.050_bb0855","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis","volume":"11","author":"Birnie","year":"2014","journal-title":"Heart Rhythm."},{"key":"10.1016\/j.ijcard.2022.03.050_bb0860","article-title":"MRI of cardiac sarcoidosis: basal and Subepicardial localization of myocardial lesions and their effect on left ventricular function","author":"Ichinose","year":"2008","journal-title":"Cardiac. Imaging Original Res."},{"issue":"2","key":"10.1016\/j.ijcard.2022.03.050_bb0865","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1161\/CIRCEP.113.000932","article-title":"Arrhythmogenic right ventricular dysplasia\/cardiomyopathy and cardiac sarcoidosis: distinguishing features when the diagnosis is unclear","volume":"7","author":"Philips","year":"2014","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"10.1016\/j.ijcard.2022.03.050_bb0870","series-title":"Usefulness of Fasting 18 F-FDG PET in Identification of Cardiac Sarcoidosis","author":"Okumura","year":"2022"},{"issue":"7","key":"10.1016\/j.ijcard.2022.03.050_bb0875","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis","volume":"11","author":"Birnie","year":"2014","journal-title":"Heart Rhythm."},{"issue":"2","key":"10.1016\/j.ijcard.2022.03.050_bb0880","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1378\/chest.123.2.406","article-title":"The diagnostic pathway to sarcoidosis","volume":"123","author":"Judson","year":"2003","journal-title":"Chest."},{"key":"10.1016\/j.ijcard.2022.03.050_bb0885","doi-asserted-by":"crossref","first-page":"2004079","DOI":"10.1183\/13993003.04079-2020","article-title":"ERS clinical practice guidelines on treatment of sarcoidosis","author":"Baughman","year":"2021","journal-title":"Eur. Respir. J."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527322004442?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527322004442?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:56:55Z","timestamp":1759093015000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527322004442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":177,"alternative-id":["S0167527322004442"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2022.03.050","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnosis and Management of Rare Cardiomyopathies in Adult and Paediatric Patients. A Position Paper of the Italian Society of Cardiology (SIC) and Italian Society of Paediatric Cardiology (SICP)","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2022.03.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}